Tag: biotech
AbCellera Biologics Stock Analysis: Buy or Sell? Valuation & Cash Burn
AbCellera Biologics Inc. (ABCL) is rated STRONG SELL as valuation still assumes a much faster clinical and commercial ramp than current results support. Despite a large cash balance, ongoing cash burn and rich revenue multiples leave little margin of safety.
Halozyme Stock Analysis: Buy or Sell? Valuation, Debt & Margins
Halozyme Therapeutics (HALO) is rated HOLD as strong ENHANZE growth and margins are balanced by a rich valuation and meaningful debt. The stock already prices in much of the platform’s success, leaving limited room for error if cash flow or EPS growth slips.
Viking Therapeutics Stock Analysis: Buy or Sell? Cash Burn & Valuation
Viking Therapeutics (VKTX) is rated STRONG SELL because heavy cash burn is consuming a large cash balance while the stock still trades at a rich valuation. Phase 3 obesity progress remains the key swing factor, but the current risk/reward looks unfavorable.
Schrödinger Stock Analysis: Buy or Sell? Valuation & Cash Burn
Schrödinger (SDGR) is rated Sell because its platform quality has not yet translated into durable cash generation. The valuation still assumes stronger growth, while operating cash flow remains deeply negative and free cash flow is not consistently positive.